USPTO 2015–2025 USPTO PatentsView US Corporation

Intermolecular, Inc.

USPTO PatentsView assignee record - 291 granted patents across 55 technology areas, active 2015–2021. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H10N (ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR).

291
Total patents granted
55
CPC technology areas
16.5
Avg claims per patent
-99%
5-year filing velocity

The verdict

Intermolecular holds 291 US patents across 55 technology areas, rank #1,434 of 50,000 tracked assignees.

#1,434
of 50,000 US assignees by volume
Top 8%
by Innovation Score (54.5/100)
16.5
avg claims per patent
-99%
filing velocity, last 5 yrs

Portfolio overview

Intermolecular, Inc. has been granted 291 US utility patents between 2015 and 2021, placing Intermolecular, Inc. at rank #1,434 across all assignees tracked by PlainPatent. This portfolio spans 55 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.5 claims per patent with primary concentration in H10N (ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR). As a US Corporation, Intermolecular, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Intermolecular sits between University Of Washington Through Its Center For Commercialization (293 patents, rank #1,430) and Dialog Semiconductor Inc. (290 patents, rank #1,438) - the closest US assignees by grant volume. The composite Innovation Score of 54.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 288 in the 2015–2019 window, a -99% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Intermolecular, Inc.'s 16.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 55 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Intermolecular, Inc. against peers pursuing similar technology classes.

Who files at Intermolecular's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Intermolecular holds 291 patents at rank #1,434, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Intermolecular

By rank, the assignees closest to #1,434 in granted patent volume.

Leaders in H10N (Electric Solid-state Devices)

Other assignees with the most granted patents in Intermolecular's primary technology class.

Intermolecular's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

55 Top 8% higher than 92% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

-50050100150200 201520162017201920202021 1
USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Intermolecular, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 182 62.5%
2016 94 32.3%
2017 11 3.8%
2019 1 0.3%
2020 2 0.7%
2021 1 0.3%

Which technologies does Intermolecular, Inc. patent most?

Top 15 of 55 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#1,434

Across all tracked assignees

Innovation Score

54.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Intermolecular, Inc. hold?
Intermolecular, Inc. holds 291 US granted patents filed between 2015 and 2021, spanning 55 technology areas.
What is Intermolecular, Inc.'s Innovation Score?
Intermolecular, Inc. has an Innovation Score of 54.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Intermolecular, Inc. focus on?
Intermolecular, Inc.'s top technology area is H10N (ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR) with 123 patents. The company has filed patents in 55 CPC subclasses total.
Is Intermolecular, Inc.'s patent filing rate increasing or decreasing?
Intermolecular, Inc.'s recent filing velocity is -99% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Intermolecular, Inc.'s patents?
Intermolecular, Inc.'s patents average 16.5 claims each. This falls within the standard range, providing solid legal coverage.
How is the Intermolecular, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Intermolecular's 291 grants land it in the top 8% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Intermolecular ranks #1,434 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in H10N - see who else leads that technology area. H10N leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.